Related Experiment Video

Updated: Aug 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up

M C Mammel, C Fiterman, M Coleman

    Developmental Pharmacology and Therapeutics
    |January 1, 1987
    PubMed

    Insights

    Short-term dexamethasone therapy improved respiratory support in infants with bronchopulmonary dysplasia (BPD), leading to extubation and comparable outcomes to hyaline membrane disease (HMD) patients without long-term sequelae.

    Area of Science:

    • Neonatal Medicine
    • Pediatric Pulmonology
    • Pharmacology

    Background:

    • Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants.
    • Ventilator-dependent infants with BPD often require prolonged respiratory support.
    • Early intervention strategies are crucial for improving outcomes in BPD.

    Purpose of the Study:

    • To evaluate the efficacy and safety of short-term dexamethasone treatment in ventilator-dependent infants with early bronchopulmonary dysplasia.
    • To compare the clinical course and outcomes of BPD infants treated with dexamethasone to those with uncomplicated hyaline membrane disease (HMD).

    Main Methods:

    • Eight ventilator-dependent infants with BPD received dexamethasone (0.5 mg/kg/day) for 7 days, followed by a 2-week taper.
    • Clinical data, including ventilator settings and oxygen requirements, were compared to 8 infants with uncomplicated HMD.
    • Incidence of complications, blood pressure, and neurodevelopmental outcomes at 1 year were assessed.

    Main Results:

    • Dexamethasone therapy significantly improved ventilator rates, peak inspiratory pressures, mean airway pressures, FiO2, and alveolar-arterial oxygen gradients within 7 days.
    • BPD infants were extubated after an average of 6.5 days of therapy.
    • Short-term dexamethasone treatment showed minimal complications, with no significant differences in septicemia, rickets, or retinopathy of prematurity compared to HMD infants. Arterial hypertension was transient.

    Conclusions:

    • Short-term dexamethasone therapy is effective in improving respiratory parameters in early bronchopulmonary dysplasia.
    • The treatment facilitated early extubation and resulted in outcomes comparable to infants with uncomplicated hyaline membrane disease.
    • Dexamethasone, when used as short-term therapy, demonstrated minimal complications and no long-term sequelae in this cohort.

    More Related Videos

    Intratracheal Instillation of Stem Cells in Term Neonatal Rats04:27

    Intratracheal Instillation of Stem Cells in Term Neonatal Rats

    Published on: May 4, 2020

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

    Published on: October 31, 2025

    Related Concept Videos

    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    Pulmonary Cycle: Exhalation01:17

    Pulmonary Cycle: Exhalation

    In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
    Pneumothorax-II01:27

    Pneumothorax-II

    Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
    Clinical Manifestations:
    Endoscopic Studies II: Thoracocentesis01:26

    Endoscopic Studies II: Thoracocentesis

    Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
    Description
    Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...